STOCK TITAN

111 SEC Filings

YI NASDAQ

Welcome to our dedicated page for 111 SEC filings (Ticker: YI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

The 111, Inc. (NASDAQ: YI) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as a foreign private issuer. 111, Inc. furnishes current reports on Form 6-K under the Securities Exchange Act of 1934, which include exhibits such as unaudited quarterly financial results. Recent 6-K filings have attached press releases for the first, second, and third quarters of 2025, outlining segment performance, operating expenses, cash flow, and the company’s use of non-GAAP financial measures.

Through these filings, investors can review details of 111, Inc.’s B2B and B2C segments, including net revenues, cost of products sold, and gross segment profit. The filings also explain how the company calculates non-GAAP income from operations, non-GAAP net income or loss, non-GAAP net loss attributable to ordinary shareholders, and non-GAAP loss per ADS by excluding share-based compensation expenses, net of tax, from the corresponding GAAP metrics. Each filing includes a discussion of the limitations of these measures and reconciliations to the most comparable GAAP figures.

Filings may also reference liquidity and capital structure topics, such as cash, cash equivalents, restricted cash, short-term investments, and obligations to investors in 1 Pharmacy Technology that are recorded as redeemable non-controlling interests and accrued liabilities. These disclosures help readers understand the company’s financial position and obligations as part of its tech-enabled healthcare platform operations in China.

On Stock Titan, 111, Inc.’s filings are updated as new documents are released through EDGAR. AI-powered tools summarize key points from lengthy filings, highlight segment trends, and surface important definitions and reconciliations for non-GAAP metrics. Users can quickly scan new 6-Ks for changes in operating performance, cash flow, and strategic commentary, while still having access to the full original documents for deeper analysis.

Rhea-AI Summary

111, Inc. director Teo Nee Chuan filed an initial ownership report showing holdings of 19,984 RSUs tied to Class A ordinary shares. Each RSU represents a contingent right to receive one Class A share, and all of these RSUs were fully vested as of the Form 3 date.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

111, Inc. director Luo Jun Justin filed an initial ownership report showing holdings of 18,366 RSUs tied to Class A ordinary shares. Each RSU represents a contingent right to receive one Class A ordinary share, and the filing notes that all such RSUs have fully vested as of the date of the Form 3. This filing records existing ownership and does not reflect any new buy or sell transaction.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

111, Inc. director Sun Jian David filed an initial statement of beneficial ownership showing fully vested restricted stock units (RSUs) in the company. The filing reports direct ownership of 18,366 RSUs tied to Class A ordinary shares. Each RSU represents a contingent right to receive one Class A ordinary share, and all of these RSUs are stated to be fully vested as of the Form 3 date.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

111, Inc. director Chen Yang Luke filed an initial ownership report showing his equity position in the company. The filing lists 126,295 RSUs (Class A) held directly. Each RSU represents a contingent right to receive one Class A ordinary share, and all of these RSUs are fully vested as of the filing date.

This Form 3 does not report any new purchase or sale activity; it simply establishes Luke’s existing beneficial ownership in 111, Inc.’s Class A equity through fully vested RSUs.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

111, Inc. filed an initial ownership report showing director Liu Junling’s equity stake in the company. The filing lists direct ownership of 36,000,000 Class B shares and 1,454,886 Class A ADSs. It also discloses 343,080 Class A RSUs, each representing one Class A ordinary share, all of which have fully vested as of this Form 3 date.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

111, Inc. board member Gang Yu filed an initial Form 3 detailing his existing equity interests in the company. As of this filing, he holds 36,000,000 Class B shares, 176,000 Class A ADSs, and 292,362 vested RSUs tied to Class A ordinary shares. He also has 750 additional Class A RSUs outstanding, each representing a right to receive one share at no cash cost before they expire on 2029-12-31.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.93%
Tags
current report
-
Rhea-AI Summary

111, Inc., a China-based company listed in the U.S., submitted a foreign issuer report for September 2025. The report mainly serves to provide an exhibit in which the company announces its unaudited financial results for the second quarter of 2025. The document is signed on behalf of the company by Chief Executive Officer Junling Liu.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.24%
Tags
current report
-
Rhea-AI Summary

111, Inc. (YI) disclosures show a company managing liquidity through multiple bank credit facilities and operational measures while reporting improving cash generation. The Group had positive operating cash flows of RMB 263,016 for the year ended December 31, 2024 and maintained a Master Guarantee Facility with RMB 100,000 committed (RMB 50,000 undrawn at issuance). Additional facilities include a credit line up to RMB 30,000 expiring January 2026 and other working-capital arrangements drawn and repaid during 2023–2024.

Other disclosures note segment reporting for B2C and B2B, treatment of marketplace revenue as principal/agent, reverse factoring outstanding RMB nil in 2024 (was RMB 98,109 in 2023), share-based plans and repurchases at subsidiary level, and restricted PRC subsidiary capital of RMB 618,830 and RMB 639,000 not available for distribution.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
annual report
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report

FAQ

What is the current stock price of 111 (YI)?

The current stock price of 111 (YI) is $6.85 as of March 20, 2026.

What is the market cap of 111 (YI)?

The market cap of 111 (YI) is approximately 57.1M.

YI Rankings

YI Stock Data

57.12M
4.63M
Medical Distribution
Healthcare
Link
China
Shanghai

YI RSS Feed